NPFCX
Price
$60.49
Change
-$0.37 (-0.61%)
Updated
Sep 20 closing price
RNGBX
Price
$56.75
Change
-$0.08 (-0.14%)
Updated
Sep 20 closing price
Ad is loading...

NPFCX vs RNGBX

Header iconNPFCX vs RNGBX Comparison
Open Charts NPFCX vs RNGBXBanner chart's image
American Funds New Perspective C
Price$60.49
Change-$0.37 (-0.61%)
VolumeN/A
CapitalizationN/A
American Funds New Economy R2
Price$56.75
Change-$0.08 (-0.14%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
NPFCX vs RNGBX Comparison Chart
Loading...
VS
NPFCX vs. RNGBX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NPFCX is a StrongBuy and RNGBX is a Buy.

FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 145B vs. RNGBX (35.8B). NPFCX pays higher dividends than RNGBX: NPFCX (0.20) vs RNGBX (0.00). NPFCX was incepted earlier than RNGBX: NPFCX (24 years) vs RNGBX (22 years). RNGBX is a more actively managed with annual turnover of: 39.00 vs. NPFCX (17.00). NPFCX (250) and RNGBX (250) have matching initial minimum investment requirements. RNGBX annual gain was more profitable for investors over the last year : 29.77 vs. NPFCX (21.61). NPFCX return over 5 years is better than : 41.24 vs. RNGBX (35.22).
NPFCXRNGBXNPFCX / RNGBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years22 years-
Gain YTD15.48319.77678%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets145B35.8B405%
Annual Yield % from dividends0.200.00-
Returns for 1 year21.6129.7773%
Returns for 3 years-6.23-4.41141%
Returns for 5 years41.2435.22117%
Returns for 10 years62.7950.81124%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRDF2.670.14
+5.73%
Cardiff Oncology
CYBR280.609.37
+3.45%
CyberArk Software Ltd
WSR13.25-0.05
-0.38%
Whitestone REIT
ODD35.58-0.72
-1.98%
ODDITY Tech Ltd
SONN1.00-0.03
-3.37%
Sonnet BioTherapeutics Holdings